LS Pharmacare SRL
LS Pharmacare reported total assets of 44,030 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Aug 2026).
The score of LS Pharmacare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LS Pharmacare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
LS Pharmacare's financial analysis
- Solvency64.9%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LS Pharmacare
LS Pharmacare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.026.628
- VAT number
- BE1002026628
- Peppol
- Registered · 0208:1002026628 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Nov 2023
- Registered office
- 2520 Ranst
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
LS Pharmacare (SRL) has been based in Ranst since 2023, active in: business and other management consultancy activities. For 2025, it reports a net profit of 10,768 € and equity of 28,581 €; its revenue is not published. Its solvency stands at 64.9%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LS Pharmacare
Companies in the same business, of comparable size and area, outside its group.
- NLJ Management Business and other management consultancy activities Profondeville · balance sheet 44,061 €
- YFAC Business and other management consultancy activities Ixelles · balance sheet 43,993 €
- Adorba Business and other management consultancy activities Marche-en-Famenne · balance sheet 43,984 €
- Jimbee Business and other management consultancy activities Beersel · balance sheet 43,980 €
- Sfingo Advisory Business and other management consultancy activities Lier · balance sheet 43,974 €
- Scout Business and other management consultancy activities Oosterzele · balance sheet 44,096 €
- WEOP Business and other management consultancy activities Maasmechelen · balance sheet 44,103 €
- Feeling Business Business and other management consultancy activities Zaventem · balance sheet 44,105 €
Frequently asked questions about LS Pharmacare
What is the revenue of LS Pharmacare?
LS Pharmacare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LS Pharmacare?
In Belgium, the VAT number is the company number prefixed with BE: BE1002026628 for LS Pharmacare, if the company is VAT-registered. Its company number (CBE) is 1002.026.628.
Where is the registered office of LS Pharmacare?
According to the CBE register, the registered office of LS Pharmacare is in 2520 Ranst.
What is the equity of LS Pharmacare?
At the close of the 2025 financial year, the equity of LS Pharmacare amounts to 28,581 €, a solvency of 64.9% of total assets.
Who manages LS Pharmacare?
The register lists 1 active mandates at LS Pharmacare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LS Pharmacare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →